An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
about
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective StudyDevelopment and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates.
P2860
An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
An update on clinical utility ...... on in treatment-naïve patients
@ast
An update on clinical utility ...... on in treatment-naïve patients
@en
An update on clinical utility ...... on in treatment-naïve patients
@nl
type
label
An update on clinical utility ...... on in treatment-naïve patients
@ast
An update on clinical utility ...... on in treatment-naïve patients
@en
An update on clinical utility ...... on in treatment-naïve patients
@nl
prefLabel
An update on clinical utility ...... on in treatment-naïve patients
@ast
An update on clinical utility ...... on in treatment-naïve patients
@en
An update on clinical utility ...... on in treatment-naïve patients
@nl
P2860
P3181
P356
P1476
An update on clinical utility ...... on in treatment-naïve patients
@en
P2093
Putcharoen
Stephen Kerr
P2860
P304
P3181
P356
10.2147/HIV.S25712
P407
P577
2013-09-16T00:00:00Z